Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization

AIM: Evaluation of real-world outcomes of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy in the primary treatment of choroidal neovascularization (CNV) secondary to pathological myopia. PATIENTS AND METHODS: A retrospective cohort analysis of treatment naive patients with m...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatia, Devangna, Mehta, Alexander, DaCosta, Joanna, Crothers, Oonagh, Talks, James Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240844/
https://www.ncbi.nlm.nih.gov/pubmed/34211264
http://dx.doi.org/10.2147/OPTH.S311816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240844/
https://www.ncbi.nlm.nih.gov/pubmed/34211264
http://dx.doi.org/10.2147/OPTH.S311816

Ejemplares similares